Digital Health Advertising and Social Media Campaigns launching alongside new site Currently in discussion with major retailers to increase distribution of EZ Detect™ Colon Disease Test IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced… Read More
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a… Read More
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% [ 1 ] (approximately 20 million patients) Broadens InFoods global patent coverage with recently allowed patents in Korea and Japan IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) —… Read More
Biomerica to Participate in Upcoming Investor Conferences
IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor conferences: the Truist Life Sciences Series and LD Micro Invitational… Read More
Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
Less invasive nasal swab taken from front opening of the nose is more comfortable for patients Test can be performed by doctors, school and company nurses, and medical assistants, in any location without specialized equipment IRVINE, Calif., May 11, 2021… Read More
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods diagnostic guided therapy technology, including the first Japanese patent InFoods IBS diagnostic-guided therapy clinical trial expecting top… Read More